13F manager/STRO/

Baillie Gifford trim Sutro Biopharma, Inc.

Baillie Gifford trim $89.8K of disclosed value in Sutro Biopharma, Inc..

Signal
Investor Move
Action
Trim
Capital
$89.8K disclosed value

Why it matters

This action comes from parsed SEC 13F holdings and highlights where tracked institutional capital changed materially versus the previous comparable filing period.

Evidence